Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:

Saturday, April 26, 2014

Using nanoparticles, not needles, to deliver drugs into the eye

Getting through the mucous on the eye this way would seem to be similar to trying to deliver drugs through the nasal cavity to the brain. Your doctor and researcher (If any good at all) will immediately recognize the potential. Or not, since we don't seem to have anyone with brains that publicly writes about this stuff.  Does your doctor know about any of these 12 or the newest one?

1.  Brain Targetting through Intranasal Route
2.  New Therapy for MS on Horizon?
3.  Nasal Administration of Recombinant Osteopontin Attenuates Early Brain Injury After Subarachnoid Hemorrhage
4.  Intranasal pyrrolidine dithiocarbamate decreases brain inflammatory mediators and provides neuroprotection after brain hypoxia–ischemia in neonatal rats

5.  Toward the First Nose Drops to Treat Brain Cancer

6.  Intranasal drug delivery disruptor OptiNose signs licensing deal for migraine treatment

7.  Intranasal VEGF - A and VEGF - E in a modified Levine model of stroke

8.  UW Spinoff Impel Neuropharma Passes Key Nose-to-Brain Clinical Trial 
9.  Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study

10.  aFGF delivered intranasally induces neurogenesis

11.  TGF alpha and stroke rehab

12.  A Nasal Spray against Alzheimer's Disease and Stroke
The newest one here:













No comments:

Post a Comment